Text Size
32 studies found for:    NIAID | Open Studies | Exclude Unknown

Modify this search | How to Use Search Results

Show Display Options
Download search resultsDownload the search results for:
NIAID | Open Studies | Exclude Unknown (32 records)
Need help? See Downloading Content for Analysis
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting Donor Stem Cell Transplantation for Congenital Immunodeficiencies
Conditions: MUD Transplant;   AlloPBSC;   Congenital Immunodeficiencies;   HLA Matched Transplant;   BMT
Interventions: Drug: Busulfan;   Drug: Campath-1 H;   Drug: Sirolimus;   Procedure: BMT;   Procedure: Apheresis;   Procedure: Total Body Irradiation;   Procedure: GCSF Injections
2 Not yet recruiting Discovery and Validation of Proteogenomic Biomarker Panels in Liver Transplant Recipients
Condition: Proteogenomic Monitoring in Liver Transplant Recipients
Intervention:
3 Recruiting Serial Blood and Urine Monitoring Study in Kidney Transplant Recipients
Condition: Kidney Transplantation
Intervention:
4 Recruiting Collection of Samples and Data for the National Marrow Donor Program Repository
Condition: Hematopoietic Stem Cell Transplantation
Intervention:
5 Available Immunosuppressive Medications for Participants in ITN005CT (NCT00014911)
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Sirolimus;   Drug: Tacrolimus;   Drug: Mycophenolate mofetil;   Drug: Mycophenolic acid
6 Recruiting Gene Therapy for Chronic Granulomatous Disease
Condition: Chronic Granulomatous Disease
Intervention: Drug: Phagocyte Oxidase Subunit Transduced CD34 Hematopoietic Stem Cells
7 Not yet recruiting Safety and Efficacy of a Steroid-free, Calcineurin Inhibitor-free, Belatacept-based Immunosuppressive Regimen
Conditions: Kidney Transplantation;   Transplantation
Interventions: Biological: Anti-thymocyte Globulin (Rabbit);   Biological: Belatacept;   Drug: Methylprednisolone;   Biological: basiliximab;   Drug: Mycophenolate Acid;   Drug: Tacrolimus
8 Recruiting Allo-antibodies in Pediatric Heart Transplantation
Condition: Pediatric Heart Transplantation
Interventions: Drug: Induction Therapy (anti-T cell antibody induction);   Drug: Tacrolimus (Prograf);   Drug: Mycophenolate Mofetil- MMF (CellCept);   Procedure: Intraoperative plasma exchange/pheresis;   Procedure: Short-term post-operative plasmapheresis;   Drug: Post-transplant course of intravenous immunoglobulin (IVIG) therapy.;   Drug: Prednisone
9 Recruiting Viral Triggers in Pediatric Lung Transplantation
Conditions: Lung Transplant;   Bronchiolitis Obliterans;   Obliterative Bronchiolitis
Intervention:
10 Not yet recruiting Safety and Efficacy of Desensitization Therapy in Sensitized Participants Awaiting Heart Transplantation
Conditions: Transplantation;   Organ Transplantation;   Heart Transplantation
Interventions: Drug: Bortezomib;   Procedure: Plasmapheresis on days 0, 1 and 2.
11 Recruiting Efficacy of Islet After Kidney Transplantation
Condition: Type 1 Diabetes Mellitus
Intervention: Biological: Islet transplant
12 Recruiting Research Study of ATG and Rituximab in Renal Transplantation
Condition: Acute Kidney Injury
Interventions: Drug: ATG;   Drug: Rituximab;   Drug: Tacrolimus;   Drug: Sirolimus;   Drug: MMF
13 Recruiting Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients
Condition: Transplantation, Liver
Intervention: Other: Immunosuppression withdrawal (ISW)
14 Recruiting Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation
Condition: Diabetes Mellitus, Type I
Interventions: Drug: Low Molecular Weight Sulfated Dextran (LMW-SD);   Drug: Heparin;   Drug: CellCept® (Mycophenolate mofetil) OR Rapamune® (Sirolimus);   Drug: Prograf® (Tacrolimus) OR Cyclosporine;   Drug: Thymoglobulin® (Anti-thymocyte Globulin) - at first transplant;   Drug: Simulect® (Basiliximab) - at 2nd or 3rd transplant;   Drug: Klexane® (Enoxaparinsodium);   Drug: Trombyl® or Albyl-E® (Acetylsalicylicacid- ASA);   Drug: Enbrel® (Etanercept)
15 Recruiting Genomics of Kidney Transplantation
Condition: Kidney Transplantation
Intervention:
16 Recruiting Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation
Condition: Kidney Transplant
Interventions: Drug: Tacrolimus + MMF + Prednisone, followed by Tacrolimus Withdrawal;   Drug: MMF/Tacrolimus/Prednisone
17 Recruiting Perceived Barriers to Patient Adherence After Pediatric Solid Organ Transplantation
Condition: Organ Transplantation
Intervention:
18 Recruiting Optimization of NULOJIX® (Belatacept) Usage as a Means of Minimizing CNI Exposure in Simultaneous Pancreas and Kidney Transplantation
Condition: Pancreas and Kidney Transplant
Interventions: Biological: Belatacept;   Drug: Medrol;   Biological: Anti-thymocyte Globulin;   Drug: Tacrolimus;   Drug: Mycophenolate mofetil
19 Recruiting Delayed Tolerance in Recipients of Living Kidney Allografts by Donor Stem Cell Infusion
Condition: Kidney Transplantation
Intervention: Biological: Hematopoietic Stem Cell Transplant/novel platform technology
20 Recruiting Thymus Transplantation Safety-Efficacy
Conditions: Complete DiGeorge Anomaly;   DiGeorge Syndrome;   DiGeorge Anomaly;   Complete DiGeorge Syndrome
Interventions: Biological: Thymus Tissue for Transplantation;   Procedure: Blood Draw;   Drug: Rabbit anti-thymocyte globulin;   Drug: Cyclosporine;   Drug: Tacrolimus;   Drug: Methylprednisolone or Prednisolone;   Drug: Basiliximab;   Drug: Mycophenolate mofetil
To Top

Previous Page Studies Shown (1-20) Next Page (21-32) Show next page of results
† Indicates status has not been verified in more than two years